ILA ASX News

26 November 2024

ISLA-101 shows anti-dengue activity in Phase 2a readout

ISLA-101 demonstrates anti-dengue activity with no safety concerns in Phase 2a trial.

Island Pharmaceuticals Dengue Fever Clinical Trials Biotechnology Stock Market News

Posted on: 26/11/2024

24 November 2024

Trading Halt

Island Pharmaceuticals halts trading pending a crucial study update.

Island Pharmaceuticals Trading Halt PROTECT Study ASX Clinical Trials

Posted on: 24/11/2024

21 November 2024

Receipt of R&D tax refund for FY2024

Island Pharmaceuticals secures $865,230 R&D tax refund, repays Radium Capital loan.

Island Pharmaceuticals R&D Tax Refund ASX Antiviral Drug Development Stock Market News

Posted on: 21/11/2024

18 November 2024

Clinical trial progress update

Island Pharmaceuticals progresses ISLA-101 trial for dengue fever prevention and treatment.

Island Pharmaceuticals Dengue Fever Clinical Trials Pharmaceuticals Stock Market News

Posted on: 18/11/2024